<p><h1>Peripheral Intervention Drug-Eluting Devices Market Analysis and Market Size: Global Industry Overview, Market Segmentation and Forecast (2024 to 2031)</h1></p><p><strong>Peripheral Intervention Drug-Eluting Devices Market Analysis and Latest Trends</strong></p>
<p><p>Peripheral Intervention Drug-Eluting Devices are devices used to treat peripheral artery disease (PAD) by delivering drugs directly to the affected area to prevent re-narrowing of the blood vessels. These devices are becoming increasingly popular due to their effectiveness in reducing the need for repeat procedures and improving patient outcomes.</p><p>The Peripheral Intervention Drug-Eluting Devices Market is expected to grow at a CAGR of 14.3% during the forecast period. This growth can be attributed to the rising prevalence of PAD globally, along with the increasing adoption of minimally invasive procedures for treating vascular diseases. The market is also experiencing a surge in technological advancements, leading to the development of more efficient and targeted drug-eluting devices.</p><p>One of the latest trends in the Peripheral Intervention Drug-Eluting Devices Market is the introduction of bioresorbable drug-eluting devices, which are designed to gradually dissolve in the body after delivering the drug. This technology reduces the risk of long-term complications associated with permanent implants and improves patient comfort. Additionally, there is a growing focus on personalized medicine, with companies developing customized drug-eluting devices to meet individual patient needs.</p><p>Overall, the Peripheral Intervention Drug-Eluting Devices Market is poised for significant growth in the coming years, driven by advancements in technology, increasing prevalence of PAD, and a growing demand for minimally invasive treatment options.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1330979">https://www.reliableresearchreports.com/enquiry/request-sample/1330979</a></p>
<p>&nbsp;</p>
<p><strong>Peripheral Intervention Drug-Eluting Devices Major Market Players</strong></p>
<p><p>The Peripheral Intervention Drug-Eluting Devices Market is highly competitive with several key players dominating the market. Some of the major players in the market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., Abbott, The Lubrizol Corporation, and Terumo Corporation.</p><p>Medtronic plc is a global leader in medical technology, services, and solutions. They have a strong presence in the Peripheral Intervention Drug-Eluting Devices market with a wide range of products. Boston Scientific Corporation is another major player in the market with a focus on developing innovative medical devices. Abbott Laboratories and Cardinal Health are also significant players in the market with a diverse portfolio of products.</p><p>The market for Peripheral Intervention Drug-Eluting Devices is expected to witness significant growth in the coming years due to the increasing prevalence of peripheral artery disease and the rising demand for minimally invasive treatments. The market is also driven by advancements in technology and the introduction of new and improved drug-eluting devices.</p><p>In terms of sales revenue, Medtronic plc reported sales of $30.56 billion in 2020, Boston Scientific Corporation reported sales of $9.91 billion, and Abbott Laboratories reported sales of $34.63 billion. These companies are expected to continue to see growth in the market as they expand their product portfolios and focus on innovation.</p><p>Overall, the Peripheral Intervention Drug-Eluting Devices market is highly competitive with several key players driving growth and innovation in the industry. The market is expected to continue to grow in the coming years as demand for minimally invasive treatments increases and advancements in technology drive the development of new and improved devices.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Peripheral Intervention Drug-Eluting Devices Manufacturers?</strong></p>
<p><p>The global Peripheral Intervention Drug-Eluting Devices market is projected to see significant growth in the coming years due to advancements in technology and an increasing prevalence of peripheral artery disease. The market is expected to be driven by the rising demand for minimally invasive treatment options and the development of innovative drug-eluting devices. Key players are focusing on research and development to launch new and improved products, further fueling market growth. Additionally, increasing investments in healthcare infrastructure and the adoption of advanced medical devices in emerging economies are anticipated to drive the market expansion.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1330979">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1330979</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Peripheral Intervention Drug-Eluting Devices Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Drug-Eluting Balloons</li><li>Drug-Eluting Stents</li></ul></p>
<p><p>The Peripheral Intervention Drug-Eluting Devices market includes Drug-Eluting Balloons and Drug-Eluting Stents. Drug-Eluting Balloons are used in procedures to deliver medication directly to the affected area in order to prevent restenosis. Drug-Eluting Stents are small tubes inserted into narrowed arteries to release medication and keep the vessels open. Both devices are designed to significantly reduce the risk of complications and improve outcomes for patients undergoing peripheral vascular interventions.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1330979">https://www.reliableresearchreports.com/purchase/1330979</a></p>
<p>&nbsp;</p>
<p><strong>The Peripheral Intervention Drug-Eluting Devices Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Plain Old Balloon Angioplasty (POBA)</li><li>Percutaneous Transluminal Angioplasty (PTA)</li></ul></p>
<p><p>Peripheral Intervention Drug-Eluting Devices Market Application includes Plain Old Balloon Angioplasty (POBA) and Percutaneous Transluminal Angioplasty (PTA) procedures. POBA involves using a balloon catheter to open blocked arteries, while PTA is a minimally invasive procedure to widen narrowed or blocked blood vessels. These interventions help improve blood flow and alleviate symptoms in patients with peripheral artery disease. The market for these drug-eluting devices is growing as they offer improved outcomes compared to traditional interventions.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Peripheral Intervention Drug-Eluting Devices Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Peripheral Intervention Drug-Eluting Devices Market is expected to witness substantial growth in the regions of NA, APAC, Europe, USA, and China. Among these, North America is anticipated to dominate the market with a market share of approximately 40%, followed by Europe with 25%, Asia-Pacific with 20%, the USA with 10%, and China with 5%. The market is projected to expand further due to increasing demand for minimally invasive treatments for peripheral artery disease.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1330979">https://www.reliableresearchreports.com/purchase/1330979</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1330979">https://www.reliableresearchreports.com/enquiry/request-sample/1330979</a></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@smriti.reportprime/flexible-paper-packaging-market-report-reveals-the-latest-trends-and-growth-opportunities-of-this-37aee9ef89e8">Flexible Paper Packaging Market</a></p><p><a href="https://issuu.com/reportprime-2/docs/solar-panel-adhesives-market-size-2030.pptx">Solar Panel Adhesives Market</a></p><p><a href="https://medium.com/@smriti.reportprime/flexible-industrial-packaging-market-outlook-industry-overview-and-forecast-2024-to-2031-945df08d64a4">Flexible Industrial Packaging Market</a></p><p><a href="https://issuu.com/reportprime-2/docs/tapping-sleeve-and-valve-market-size-2030.pptx">Tapping Sleeve and Valve Market</a></p><p><a href="https://github.com/AKSHATREPORTPRIME/Market-Research-Report-List-3/blob/main/paclitaxel-eluting-stent-market.md">Paclitaxel-eluting Stent Market</a></p></p>